中医延续性护理对提高特发性肺纤维化患者生活质量调查研究(3)
本研究是一项短期中期 IPF 患者的研究课题,中医延续性护理是否对 IPF 晚期患者有效,是否可以延长患者生存时间等情况还有待进一步研究。
参考文献:
[1]Raghu G,Collard HR,Egan JJ,et al.An Official AST/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidencebased guidelines for diagnosis and management[J].Am J Respir Crit Care Med,2011,183(6):788-824.
[2]Bradley B,Branley HM,Egan JJ,et al,Interstitial lung disease guideline:the British Thoracic Society in collaboration with the ThoracicSociety of Australia and New Zealand and the Irish Thoracic Society[J].Thorax,2008,63(5):1-58.
[3]Swigris J J,Wilson S R,Green K E,et al.Development of the ATAQ-IPF:a tool to assess quality of life in IPF[J].Health QualLife Outcomes,2010,8:77.
[4]崔璦,代华平.特发性肺纤维化诊治进展:从“专家共识”到以循证医学证据为基础的“诊治指南”[J].中国医学前沿杂志(电子版),2012,4(1):51-54.
[5]焦扬,关天宇,周平安.肺痹汤对肺纤维化大鼠肺组织中 p38分裂原激活 蛋白酶及转化生长因子β1的影响[J].中医杂志,2007,48(3):259-261.
[6]徐洪洁,吕晓东,庞立健,等.特发性肺纤维化的“纲目经纬”中医辨证施护[J].中国中医基础医学杂志,2012,18(6):676-678.
[7]Strieter R M,Mehrad B.New mechanisms of pulmonary fibrosis[J].CHEST Journal,2009,136(5):1364-1370.
(收稿日期:2020-04-14), 百拇医药(沈云霞 孟晶晶 管娟 张桂兰)
参考文献:
[1]Raghu G,Collard HR,Egan JJ,et al.An Official AST/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidencebased guidelines for diagnosis and management[J].Am J Respir Crit Care Med,2011,183(6):788-824.
[2]Bradley B,Branley HM,Egan JJ,et al,Interstitial lung disease guideline:the British Thoracic Society in collaboration with the ThoracicSociety of Australia and New Zealand and the Irish Thoracic Society[J].Thorax,2008,63(5):1-58.
[3]Swigris J J,Wilson S R,Green K E,et al.Development of the ATAQ-IPF:a tool to assess quality of life in IPF[J].Health QualLife Outcomes,2010,8:77.
[4]崔璦,代华平.特发性肺纤维化诊治进展:从“专家共识”到以循证医学证据为基础的“诊治指南”[J].中国医学前沿杂志(电子版),2012,4(1):51-54.
[5]焦扬,关天宇,周平安.肺痹汤对肺纤维化大鼠肺组织中 p38分裂原激活 蛋白酶及转化生长因子β1的影响[J].中医杂志,2007,48(3):259-261.
[6]徐洪洁,吕晓东,庞立健,等.特发性肺纤维化的“纲目经纬”中医辨证施护[J].中国中医基础医学杂志,2012,18(6):676-678.
[7]Strieter R M,Mehrad B.New mechanisms of pulmonary fibrosis[J].CHEST Journal,2009,136(5):1364-1370.
(收稿日期:2020-04-14), 百拇医药(沈云霞 孟晶晶 管娟 张桂兰)